170 related articles for article (PubMed ID: 27930864)
1. TERT promoter mutations are not always associated with poor prognosis in atypical spitzoid tumors.
Requena C; Heidenreich B; Kumar R; Nagore E
Pigment Cell Melanoma Res; 2017 Mar; 30(2):265-268. PubMed ID: 27930864
[No Abstract] [Full Text] [Related]
2. Two novel H-RAS mutations identified in a child with an atypical spitzoid tumor.
Simi L; Pinzani P; Salvianti F; Lorenzoni A; Tomasini C; Broganelli P; Orlando C; Pazzagli M; Massi D
Arch Dermatol; 2011 Apr; 147(4):514-5. PubMed ID: 21482913
[No Abstract] [Full Text] [Related]
3. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.
Takata M; Lin J; Takayanagi S; Suzuki T; Ansai S; Kimura T; Cerroni L; Saida T
Br J Dermatol; 2007 Jun; 156(6):1287-94. PubMed ID: 17535228
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of spitzoid tumours: A clinical study.
Hafiji J; Rytina E; Burrows NP
Australas J Dermatol; 2012 Aug; 53(3):211-5. PubMed ID: 22671697
[TBL] [Abstract][Full Text] [Related]
6. Atypical Spitz Tumors: A Diagnostic Challenge.
Harms KL; Lowe L; Fullen DR; Harms PW
Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
Yagi S; Balzer BL; Frishberg DP; Shon W
J Cutan Pathol; 2020 Dec; 47(12):1228-1232. PubMed ID: 32710563
[No Abstract] [Full Text] [Related]
8. A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis.
Kastnerova L; Martinek P; Grossmann P; Steiner P; Vanecek T; Kyclova J; Ferak I; Zalud R; Slehobr O; Svajdler P; Sulc M; Bradamante M; Banik M; Hadravsky L; Sticova E; Hajkova V; Ptakova N; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Aug; 42(8):578-592. PubMed ID: 32701692
[TBL] [Abstract][Full Text] [Related]
9. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
[TBL] [Abstract][Full Text] [Related]
10. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
[TBL] [Abstract][Full Text] [Related]
11. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
Urso C
Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
[No Abstract] [Full Text] [Related]
12. Classic and atypical Spitz nevi: review of the literature.
Helm TN; Helm KE
Cutis; 2007 Sep; 80(3):183; author reply 183. PubMed ID: 17956003
[No Abstract] [Full Text] [Related]
13. Allelic imbalance in the diagnosis of benign, atypical and malignant Spitz tumours.
van Dijk MC; Rombout PD; Mooi WJ; van de Molengraft FJ; van Krieken JH; Ruiter DJ; Ligtenberg MJ
J Pathol; 2002 Jun; 197(2):170-8. PubMed ID: 12015740
[TBL] [Abstract][Full Text] [Related]
14. Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour.
Cesinaro AM; Schirosi L; Bettelli S; Migaldi M; Maiorana A
Histopathology; 2010 Oct; 57(4):515-27. PubMed ID: 20860655
[TBL] [Abstract][Full Text] [Related]
15. TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.
Lee S; Barnhill RL; Dummer R; Dalton J; Wu J; Pappo A; Bahrami A
Sci Rep; 2015 Jun; 5():11200. PubMed ID: 26061100
[TBL] [Abstract][Full Text] [Related]
16. The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.
Wu G; Barnhill RL; Lee S; Li Y; Shao Y; Easton J; Dalton J; Zhang J; Pappo A; Bahrami A
Mod Pathol; 2016 Apr; 29(4):359-69. PubMed ID: 26892443
[TBL] [Abstract][Full Text] [Related]
17. TERT Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms.
Boutko A; Asadbeigi S; Roth A; Lampley N; Olivares S; Dittmann D; Dittmann D; Jennings L; Gerami P
Am J Dermatopathol; 2023 May; 45(5):289-299. PubMed ID: 36898007
[TBL] [Abstract][Full Text] [Related]
18. Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
Quan VL; Zhang B; Zhang Y; Mohan LS; Shi K; Wagner A; Kruse L; Taxter T; Beaubier N; White K; Zou L; Gerami P
J Invest Dermatol; 2020 Aug; 140(8):1599-1608. PubMed ID: 32004563
[TBL] [Abstract][Full Text] [Related]
19. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms.
Tetzlaff MT; Reuben A; Billings SD; Prieto VG; Curry JL
Clin Lab Med; 2017 Sep; 37(3):431-448. PubMed ID: 28802494
[TBL] [Abstract][Full Text] [Related]
20. TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis.
Motaparthi K; Kim J; Andea AA; Missall TA; Novoa RA; Vidal CI; Fung MA; Emanuel PO
J Cutan Pathol; 2020 Aug; 47(8):710-719. PubMed ID: 32202662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
